Telix gets FDA Fast Track for BiPASS pre-biopsy prostate cancer imaging study
Fast Track was granted for BiPASS, a Phase 3 program testing 68Ga PSMA-PET with MRI before prostate biopsy; Phase 3 enrollment is complete and no results were reported.
Fast Track was granted for BiPASS, a Phase 3 program testing 68Ga PSMA-PET with MRI before prostate biopsy; Phase 3 enrollment is complete and no results were reported.